Get the app!
Back to Trades
Other4

AMGEN INC

AMGN

Total Value
$147.7K

Company Information

Company Name
AMGEN INC
Ticker Symbol
AMGN
CIK
0000318154

Insider Information

Role
EVP, Research and Development
Officer
Location
THOUSAND OAKS, CA

Filing Details

Filing Date
May 11, 2026
Transaction Date
May 7, 2026
Accession Number
0000318154-26-000083
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
May 7, 2026Common Stock446$331.11Tax Withholding$147.7K

Footnotes

  1. (F1)These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.